CRB is proud to announce that the Amicus Therapeutics Research and Gene Therapy Center facility has won Engineering News-Record (ENR) MidAtlantic’s 2020 Best Projects (Award of Merit) in the Healthcare category.

Two panels of industry judges reviewed more than 80 projects located throughout the region, including Delaware, Maryland, Pennsylvania, Virginia, West Virginia, and the District of Columbia. Projects were scored on the ability of the project team to overcome challenges, contribution to the industry and community, project innovation, safety, and construction/design quality.

Amicus is a biopharmaceutical company that discovers and develops medicines for rare diseases. It’s global research and gene therapy center of excellence consolidates Amicus’ five research departments into a unified space on the top two floors of a 14-story tower. The research workplace is the convergence of technical laboratories, office, and amenity spaces. The design creates spaces that connect science, people and purpose.

Our team provided architectural, engineering, and lab design to realize our client’s vision: a standout research facility that would attract and retain top researchers, promote collaboration, and break down barriers between employees to rapidly advance these potentially life-saving therapies through the drug pipeline.

To read more about the ENR 2020 Best Projects, click here. 

CRB

CRB

CRB is a leading global provider of sustainable engineering, architecture, construction, and consulting solutions to the life sciences and food and beverage industries. Our innovative ONEsolution™ service provides successful integrated project delivery for clients demanding high-quality solutions -- on time and on budget. Across 21 offices in North America and Europe, the company's nearly 1,800 employees provide world-class, technically preeminent solutions that drive success and positive change for clients and communities. See our work at crbgroup.com, and connect with us on social media here.

More from CRB